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Abstract
Hypertrophic cardiomyopathy (HCM) is one of the most common cardiac genetic disorders. The prevalence of this dis-
ease is 1 in 500 live births. It is stated to be the most frequent cause of sudden death in young adults. Therefore, some 
guidelines recommend to restrict physical activity and exercise. On the contrary, latest data show that active lifestyle and 
exercise in HCM patient provide significant benefits in cardiovascular function with no significant adverse reactions. Fol-
lowing to that, some experts might be reveal that its benefits might be outweigh risks.
There is a paucity of studies that examine the effectiveness of exercise for HCM. American Heart Association (AHA) and 
(European Society of Cardiology) ESC established exercise recommendations for HCM individuals based on discussion and 
consensus of experts.  We found three studies that investigate the efficacy of exercise in HCM individuals. Outcomes of 
our interest were differences in cardiovascular function, quality of life and safety issues. All studies found positive significant 
differences in main outcomes measure in which the HCM subjects on exercise had better or improved outcomes. None 
reported adverse reaction such as fatal arrhythmia or sudden death related to exercise.
Old belief regarding exercise restrictions on HCM need to be reconsidered, given that at present exercise have been 
shown to provide significant benefits for reducing cardiovascular risk factors. Nevertheless, exercise in patients with HCM 
must be specifically considered regarding the risk and benefit. Practicing active lifestyle and exercise on HCM individual is 
an exciting possibility that need further study.
(Indonesian J Cardiol. 2019;40:332-340)
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Introduction
Physical activity restriction induces hypertrophic cardiomyopathy (HCM) patient to be inactive and sedentary.1-2 Problems such as obesity, coronary heart disease, type 2 diabetes mellitus 
arise as an implication of undergoing sedentary lifestyle 
that increases the risk of cardiac events.2 However, 
the relationship between exercise and sudden death 
doi: 10.30701/ijc.v40i4.839
Indonesian J Cardiol ● Vol. 40, Issue 4 ● October - December 2019 333
Indonesian Journal of Cardiology 
remains unclear, because there is insufficient scientific 
evidence.3-6
 In this article, we discuss a narrative review about 
HCM and its pathophysiology related to exercise, provide 
summary of international guideline recommendations 
and review both positive potential benefits and negative 
risks of exercise training in HCM based on currently 
clinical and experimental data in some latest studies.
Hypertrophic Cardiomyopathy
HCM is characterized by a thickened but non-
dilated left ventricle in the absence of other cardiac or 
systemic conditions (e.g., aortic valve stenosis, systemic 
hypertension, and some expressions of physiologic 
athlete’s heart) capable of producing the magnitude 
of left ventricular (LV) hypertrophy evident.4 HCM 
prevalence ranges from 0.2% - 0.5% of the total 
population worldwide (1: 500-1: 700).1,3-10  In the 
United States,  there is 600.000-700.000 individuals 
diagnosed with HCM.4,7 Meanwhile in Indonesia, there 
is no data regarding the prevalence of HCM. 
 HCM is an autosomal dominant genetic disorder 
caused by a variety of mutations in genes encoding 
sarcomeric proteins and characterized by a broad and 
expanding clinical spectrum.4 There are approximately 
1400 mutations from 11 gene types associated with 
HCM events.3 Almost 60% of HCM in adults are caused 
by mutations in the sarcomeres of the heart muscle 
protein. The most common mutations involving the 
beta-myosin heavy chain and myosin binding protein 
C account for more than 70% mutations identified in 
patient who are with genotype positive.3,4,10,11
 Pathophysiology HCM is a complex mechanism. 
Initially, there is presence of myocytes hypertrophy 
which causes several abnormalities, such as obstruction 
of Left Ventricular Outflow Tract (LVOT), diastolic 
dysfunction, mitral regurgitation, myocardial ischemia 
and arrhythmia. Those four abnormalities mentioned 
earlier cause symptoms of dyspnea, syncope or sudden 
death.4,7,12
 HCM can be asymptomatic or with severe clinical 
conditions. Typically, clinical symptoms of HCM 
appear before the age of 30-40 years.4,7 Symptoms of 
heart failure (with preserved LV function) may develop 
unpredictably at any age, with functional limitation due 
to exertional dyspnea or fatigue, and in advanced stages 
by orthopnea or paroxysmal nocturnal dyspnea.4 HCM 
end stage provides clinical features similar to heart 
failure and atrial fibrillation patient. 4,7 
 Echocardiography is a gold standard modality in 
establishing diagnosis of HCM. It is usually recognized by 
maximal LV wall thickness ≥15 mm, with wall thickness 
of 13 to 14 mm considered borderline, particularly in 
the presence of other compelling information, like 
family history of HCM. Other supporting examinations 
are cardiac magnetic imaging resonance and computed 
tomography.4,7,13
Sudden Cardiac Death in Hypertrophy Cardio-
myopathy
The risk of sudden death in HCM is recorded at only 
0.1% per year, and is dominated by athletes. HCM is 
recognized as one of the most frequent causes of sudden 
death for ages <35 years,1,3-10 as shown in figure 1.14 
However, the actual number remains unclear.3-6 Saberi 
(2017) stated that the incidence of sudden death in 
HCM is 1-3 in 100,000 cases.5 This data is similar to 
sudden death incidence in the general population.5,9,14
Figure 1. Cause of sudden death
Source : Lavie CJ, Milani RV, Mark P, Gruiter M. Exercise and 
the heart : risks, benefits, and recommendation for providing 
exercise prescriptions. The Ochsner Journ. 2001; 207-212
 Sudden death mechanism in HCM related to 
exercise is unexplained. During exercise, there are 
several physiological changes that might induce sudden 
death, such as myocardial ischemia, vagal sympathetic 
imbalance, dehydration, electrolyte disturbances, 
metabolic acidosis and hemodynamic changes. However, 
to date, there has been no validated research to prove 
the exact cause of sudden death.4,5,7 In fact, in some 
recent studies, sudden death commonly occur at rest 
condition, only about 11% occur during exercise.5 In a 
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large-scale study conducted in England involving 1380 
HCM patients given exercise testing, only 24 patients 
developed non-sustained ventricular tachycardia and 3 
patients experienced ventricular fibrillation.3
Exercise and Hypertrophic Cardiomyopathy
Factors that increase the LVOT dynamic obstruction, 
fatal arrhythmias and disease progression need to be 
considered when prescribing an exercise program. 
Most of HCM patients can live a normal life, only a 
small proportion experienced premature death and 
complications. From previous data, mortality of HCM 
patients is mostly due to non-cardiovascular causes. 
Therefore, active lifestyle is reasonable in reducing the 
risk of disease progression.5,6,10
 Intensive and rigorous exercise are hypothesized 
to cause changes in cardiac structure. It increases heart 
muscle mass and size of the left ventricle. Following 
to that, it can also be accompanied by acute right 
ventricular dysfunction. In HCM patient, there may be 
an increase in left ventricular hypertrophy, myocardial 
ischemia, myocardial fibrosis and decreased systolic and 
diastolic function.4,7 At present, there are no cohort 
studies in humans that monitor the long-term effects of 
exercise on HCM progression.3 Interestingly, in studies 
using HCM rat subjects with negative phenotypes, 
exercise prevented fibrosis and myocytes disarray hence 
there were no increase in hypertrophy. In subjects with 
positive phenotype, exercise alleviate myocytes disarray 
and markers of hypertrophy, but has no effect on 
fibrosis. Overall, there is a lack evidence study stating 
that exercise causes acceleration of HCM progression. 
3,6,15
Guideline Recommendations For Exercise in Hy-
pertrophic Cardiomyopathy
Exercise guidelines for HCM was first announced in 
1985 at Bethesda Conference. Individuals with left 
ventricular hypertrophy, LVOT obstruction, history of 
syncope and arrhythmias or a family history of sudden 
death, are prohibited from practicing competitive 
sports except for low intensity aerobic exercise such as 
bowling and golf (class IIa, level of evidence C).6,16 
HCM patient are allowed to do recreational sports (class 
IIa, level of evidence C) as shown in Table 1.16  Type 
of sports is given a score ranging from 0-5, scored 4-5 
are the most recommended, scored 2-3 require special 
evaluation, and 0-1 are strongly recommended to be 
avoid.3,6,17
 Guidelines by the American Heart Association / 
Table l. Type of sports recommended by AHA/ACC for HCM3,6
High Intensity Moderate intensity Low intensity
Sports Score Sports Score Sports Score
Basketball 0 Baseball 2 Bowling 5
Body building 1 Biking 4 Walking 5
Gymnastic 2 Hiking 3 Golf 5
Ice hockey 0 Motorcycling 3 Horse racing 3
Squash 0 Jogging 3 Scuba diving 0
Climbing 1 Sailing 3 Skating 5
Sprint 0 Surfing 2 Snorkeling 5
Skiing (downhill) 2 Swimming 5
Skiing (cross 
country)
2 Tennis (double) 4
Soccer 0 Treadmill/stationary 
bicycle
5
Tennis (single) 0 Weightlifting (free 
weight)
1
Windsurfing 1
Note :
AHA = American Heart Association, ACC= American College of Cardiology, HCM = hypertrophic cardiomyopathy
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American College of Cardiology (AHA / ACC, 2011) 
and the European Society of Cardiology (ESC, 2014) 
provide recommendations for exercise programs in 
HCM individuals. Low intensity aerobic exercise is 
the most recommended (class IIa, level of evidence C). 
Individuals are not allowed to do sports or exercise that 
are competitive, but are allowed for recreational exercise 
(class IA sports) (Figure 2). Recreational exercise is 
equivalent to low intensity (< 4 METs) to medium 
intensity (4 – 6 METs) of aerobic exercise. 3,6,17
 Patients are advised to always be vigilant with the 
intensity of the exercise, if during exercise the patient 
feels one of the cardiovascular symptoms, exercise must 
be immediately terminated.3,6,17 Experts also provide 
more specific recommendations on how HCM patients 
exercise and do recreational sports, such as to avoid 
“burst exertion” (exercise with sudden acceleration 
and deceleration phases for short distance) like sprint 
running, basketball, soccer, to avoid exercise at extreme 
ambient temperatures and in state of dehydration, to 
avoid heavy isometric exercise such as lifting weight, 
and use specifically designed exercise program to achieve 
optimal levels of conditioning.3,6,16
 In 2015, AHA issued a new consensus that 
competitive training restrictions were applied only to 
HCM positive genotypes with positive phenotypes 
(HCM LVH +). In HCM positive genotypes with 
negative phenotypes (HCM LVH-), there is no 
restriction to competitive training, as long as there are 
no family history of sudden death (class IIa, level of 
evidence C). Individuals with HCM LVH + but with no 
clinical symptoms, are still not allowed to do competitive 
training, except for low intensity exercise (class III, level 
of evidence C). HCM patient without obstruction and 
no clinical symptoms, with no history of tachycardia 
during training or ambulatory monitoring using 
holter, and no history of syncope, can be considered 
to participate in competitive exercise (class IIb, level of 
evidence C).3,18
 In 2014 the ESC also issued recommendations 
for exercise training on HCM. The recommendations 
issued are similar to those from AHA. HCM patients 
are recommended to do low intensity aerobic exercise 
(Figure 2.) and prohibited to participate in competitive 
exercise.  ESC established more stringent restrictions that 
all HCM individuals are not allowed to participate in 
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competitive sports, irrespective of their phenotypes.17,19 
Weighing Risks and Benefits of Exercise in Hy-
pertrophic Cardiomyopathy
HCM patient who are physically inactive, are still at risk 
of having other cardiovascular and metabolic diseases 
such as coronary heart disease, diabetes mellitus, stroke, 
myocardial infarction, heart failure and premature 
death. Physical inactivity is the number four cause of 
death in all cases.1 For general health, low to moderate 
intensity exercise (40-75% of maximum capacity) is a 
safe regimen and can decrease the risk of sudden death.20
 In general population, it is well acknowledged that 
exercise can reduce the risk of death. The beneficial 
effect of exercise on the structure of the heart is 
possibly caused by inhibition of apoptosis process at the 
molecular level.3,21 In a systematic review about heart 
failure patients, data shows that regular exercise can 
increase VO¬2 peak by 4-18%, this is highly correlated 
with a reduced risk of death, re-hospitalization rate and 
improvement in quality of life.22 This might be also 
apply to HCM patient, however there is a paucity of 
research on this subject.
 To date, there are still no evidence-based guidelines 
to prescribe exercise in HCM. Theoretically, rigorous and 
intense exercise might cause exacerbations of pathological 
factors that can impact to cardiovascular disorders. In 
one study concluded that HCM individuals are at risk 
of exercise-induced systolic dysfunction.3 Conversely, 
a research conducted by Dejgaard (2017) stated that 
HCM individuals who has an active lifestyle have 
better cardiovascular function compared to inactive.23 
In line with Dejgaard, in an animal study conducted 
by Kim et al, mice induced with troponin I mutations 
without HCM phenotype, showed that exercise could 
reduce heart rate and increase contraction function.15 In 
human studies, some researcher suggested that exercise 
was found to improve cardiac pathological structures in 
HCM patient by reducing myocytes disarray, decreasing 
clinical markers of ventricular hypertrophy and signal 
apoptosis.3,6,15 In addition, it was also found that exercise 
did not cause worsening of pathological structures or 
induce sudden death in experimental mice.6,15  These 
findings support latest studies conducted by Saberi 
et al which stated that exercise with low to moderate 
intensity can reduce the risk of cardiovascular events.24
 It is reasonable to apply those results to HCM 
patient due to the beneficial effects of exercise in 
cardiovascular outcomes, such as improvement in blood 
flow, autonomic function, skeletal muscle metabolism, 
and endothelial repair. However, some precaution 
need to be considered, due to the risk of alteration of 
cardiovascular function associated with exercise.6,20
Practical Guide to Individual Hypertrophic Car-
diomyopathy Exercise
Initial assessment is an important stage in determining 
exercise prescription and recommendations for HCM 
patients. It includes history, physical examination 
and supportive findings. The main components of 
initial assessment are risk stratification and patient's 
cardiorespiratory capacity.
 Individual with HCM can be stratified into high, 
intermediate or low risk category. High-risk category 
includes those who are in a sustained ventricular 
tachycardia or multiple repetitive non-sustained 
ventricular tachycardia, unexplained syncope, abnormal 
exercise blood pressure response, and massive left 
ventricle hypertrophy.3,6 History of familial sudden 
death and cardiac arrest are also in this high risk 
category.3 Some potential arbitrators, such as end stage 
phase, left ventricle apical aneurysm, marked LVOT 
at rest, extensive delayed enhancement, alcohol septal 
ablation, and coronary heart disease are included as 
intermediate and low risk category.3,6
 Patient’s cardiorespiratory capacity can be 
Table 2. Comparison between AHA/ACC and ESC 
Recommendation.6,17,19
AHA ESC
HCM LVH +
Competitive sports Class IA Class IA sports with 
low risk. If not, all 
competitive sports 
are prohibited
Recreational sports Some restrictions Some restrictions
HCM LVH-
Competitive sports No restriction Prohibited
Recreational sports No restriction No restriction
Note :
AHA = American Heart Association, ESC= European Society 
of Cardiology, HCM = hypertrophic cardiomyopathy, LVH = 
left ventricular hypertrophy
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determined by performing exercise testing. In a recent 
study, this exercise testing was a safe procedure and did 
not associate with an increase in cardiovascular risk 
factors. This test is the most accurate test in determining 
functional capacity, the physiological hemodynamic 
response to stress, the presence or absence of ischemia, or 
obstruction of the outflow tract, also helps determining 
whether clinical symptoms are really related to cardiology 
or respiration problems. The main parameters obtained 
from this procedure are peak oxygen uptake. The peak 
oxygen uptake rate is the most influential determinant 
for functional capacity. By conducting an exercise 
testing, it is possible to get results or data regarding 
the presence or absence of obstruction in HCM 
patients provoked by exercise. In addition, the patient's 
tolerance for exercise and functional limitation can also 
be determined. Following to that, recommendation of 
proper daily activities can be encouraged and tailored 
based on patient’s functional capacity.25
 The type of exercise and physical activity is also 
determined based on patient's preference. Patients select 
the type of recreational exercise with low intensity in 
accordance with the guidelines. Exercise must be carried 
out at reasonable ambient temperatures and the patient 
needs to avoid dehydration.20
 In symptomatic patients, Finocchiaro (2016) 
recommended general approach exercise prescription 
for symptomatic HCM patient. Aerobic exercise and 
static exercise are the main core. Initially, a measurement 
of heart rate at the anaerobic threshold using cycle 
ergometer with incremental ramp protocol of 10 W 
per minute is conducting, then patient is instructed 
to perform aerobic exercise for 20 minutes, 3-5 times 
a week at the heart rate coinciding with the anaerobic 
threshold (with cardiopulmonary exercise testing).20 On 
the occasion that anaerobic threshold heart rate cannot 
be determined, intensity can be set using 70-80% of 
the predicted heart rate (220-age). In patients with beta 
blockers, exercise is recommended to reach 60-70% of 
the maximum predictive heart rate. For static exercise, 
muscle strengthening can also provide benefits, but 
only at low intensity (< 20% body weight on upper 
limb, < 50% body weight on lower limbs). Isotonic 
strengthening exercise using a load of 0.5-1 kg, 20-30 
repetitions are safe to be carried out 2-3 times a week. 
On occasion patients cannot attain this level, walking 
daily or using static cycle to a point that patients can 
“talk but cannot sing.”20 This type recommendation was 
designed for home programmed exercise.
 Another recommendation in prescribing exercise for 
HCM patients conducted by Saberi et al,  a structured and 
unsupervised exercise program individually prescribed 
based on exercise testing, is safe to be performed 
in HCM patient who are not at high risk. Exercise 
prescription should be designed to increase duration 
of exercise by 5 to 10 minutes, up to 60 minutes per 
session at the level of moderate intensity. The intensity 
can be set at 60%  heart rate reserve (HRR), and then 
incrementally increase training intensity to a goal of 
70% HRR. Mode of exercise include cycling, walking 
and elliptical training.24
 Exercise training for HCM has its own uniqueness 
associated with the possibility of exercised-induced 
arrhythmia, so the security aspect is very important. 
In addition to the exercise regimen, some lifestyle 
modifications need to be adapted by HCM patients. 
HCM individuals must always pay attention to their 
diet and fluid needs. The recommended diet is a 
small but frequent portion, it should not be eaten to 
excess, because it is related to when the postprandial 
splanchnicus blood flow increases, resulting in a 
decrease in preload and increased LVOT obstruction. 
HCM individuals must also avoid dehydration because 
they can also increase LVOT obstruction. In addition, 
there are some foods that should also be avoided such as 
coffee and alcohol.2
 There is a lack literature that states about how 
cardiac rehabilitation (CR) in HCM patients should be 
performed. Someribba et al conducted an example of 
CR in cardiomyopathy patients. It is generally divided 
into 2 phases, intensive phase and maintenance phase. 
The intensive phase consists of 12 weeks of practice 
with 2 visits per week, carried out in the hospital. The 
type of exercise given is low-moderate aerobic exercise, 
on average 1 hour, including heating and cooling. 
Other types of exercises such as resistance training (low 
intensity) and flexibility training can be considered. The 
maintenance phase lasts 6 months with 2 hospital visits 
in 1 month. Exercise can be done at home. Patients must 
always be educated by modifying a healthy lifestyle.13
Evidence-Based Research For Exercise in  Hy-
pertrophic Cardiomyopathy
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There is a paucity of studies that examine the effectiveness 
of exercise for HCM. AHA and ESC established exercise 
recommendations for HCM individuals based on 
discussion and consensus of experts.17,19 We found three 
studies that investigate the efficacy of exercise in HCM 
individuals. Outcomes of our interest were differences 
in cardiovascular function, quality of life and safety 
issues. All studies found positive significant differences 
in main outcomes measure in which the HCM subjects 
on exercise had better or improved outcomes. None 
reported adverse reaction such as fatal arrhythmia or 
sudden death related to exercise.2,15,23,24
 Saberi et al (2017) used 113 HCM samples which 
were randomized into two groups; training group and 
control group (usual activities). This research is referred 
to The Randomized Exploratory Study of Exercise 
in Hypertrophic Cardiomyopathy (RESET-HCM). 
Subjects were given individualized aerobic exercise with 
moderate intensity. Each training session has a duration 
of 20 minutes initially, three sessions per week, with a 
limit of 60% HRR (resting heart rate + 0.6 (maximal 
heart rate - resting heart rate)) or using a Borg scale 
(11-14). Exercise is increased by 5-10 minutes each 
week until it reaches a maximum limit of 60 minutes. 
Increased exercise performance limits to a maximum of 
70% of HRR and exercise is continued until the 16th 
week. The types of exercise selected in this study were: 
cycling, walking, and elliptical training.24 The results 
showed that improvement in peak VO2 in training 
group increased +1.35 ml / kg / min compared to only 
0.08 ml / kg / min in non-exercise group. In exercise 
group there was no worsening of the anatomical and 
functional structures of the heart and no increase in 
LVOT obstruction. In exercise group, there is increase 
of 5.7 points in the physical function domain of the 
Short Form Health Survey (SF-36). There is no report 
regarding adverse reaction.24 This study is the first large-
scale randomized clinical trial conducted to determine 
the effect of exercise on HCM patients. 24
 In 2015, Klempfner et al. analyzed the effectiveness 
of exercise in HCM patients following a heart supervision 
program. Patients with NYHA II and III, with average 
ejection fraction at 53%. Exercise was prescribed based 
on HRR from a symptom limited graded exercise test. 
The intensity of exercise started from 50% and were 
increased gradually to 85% HRR. From this study, the 
results of functional capacity improved from 4.7 METs 
to 7.2 METs (increased by 46%), 50% of patients 
experienced improvement in NYHA ≥ 1 level, and 
none experienced a decline in functional levels, with no 
adverse reactions such as arrhythmias and sudden death 
occured.15
 Dejgaard et al conducted a study to determine 
whether HCM individuals who lived an active lifestyle 
have better cardiovascular function outcomes than 
less active individuals. In this study, 187 samples were 
Table 4. Summary of studies result
Outcomes
Saberi et al Klempner et al Dejgaard et al
E UA P Pre Post P A LA P
METs
LV-end diastolic volume (cm3/m2)
Stroke volume
EF (%) for each NYHA class
NYHA class
1.35 0.08 0.024 (6%)
II=35
III=65
4.7
I=25
II=45
III=30
7.2
0.001 (50%)
0.001
(46%)
47
58
1.6
39
47
2
0.001
0.001
0.03
Quality of life (SF-36) 5.7 -2.5 0.004
Arrhythmia event, death, appropriate 
ICD shock
No significant 
difference
Log rank 
0.36 None 11 17 0.82
LVOT obstruction No significant difference - No significant difference
Note :
E = exercise, UA = usual activity, A = active individuals, LA = less active individuals, p= p value, NYHA= New York Heart 
Association, EF= ejection fraction, ICD=implantable cardioverter-defribrillator, LVOT=left ventricle obstruction outflow
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divided into group with active lifestyle (>6 METs) and 
group with less active lifestyles (<6 METs). Interviews 
were carried out on physical activities and daily 
training in the past 6 years. All subjects underwent 
echocardiographic examination to determine cardiac 
function parameters and genetic testing was conducted 
to determine the genotype of the subject.23 The results 
of the study stated that in the group with active lifestyle 
of at least 4 hours per week with HCM LVH + had 
better NYHA functional levels than HCM LVH + with 
groups with less active lifestyle. In HCM LVH + and 
HCM LVH - , the active lifestyle has a better end-systolic 
volume and ventricular diastolic end. The incidence of 
arrhythmia in group active lifestyle is 11 samples and in 
group of less active lifestyle is 17 samples; which are not 
correlated with exercise.23
Table 3. Summary of training protocol15,23,24
Training 
protocol Saberi et al Klempner et al
Dejgaard 
et al
Frequency 3x/weeks 2x/weeks (CR)
Community 
walking 2x 
weeks (RPE 
11-12)
Daily
Total 
duration
16 weeks Mean 41± 8 h 4 hours/
weeks /
throughout 
the year
Exercise Ergocycle, 
brisk walking, 
elliptical 
training
Treadmill, arm 
ergocycle, static 
cycle
Self-selected 
(cycling)
Intensity Initial : 60% 
HRR
Up to 70% 
HRR
Initial : 50-60% 
HRR
Up to 85% 
HRR
Activities >6 
METs
Note :
CR = Cardiac Rehabilitation, RPE= Rate Perceived Exertion, 
HRR = heart rate reserve, METs = Metabolic Equivalents
Conclusion
Old belief regarding exercise restrictions on HCM need 
to be reconsidered, given that at present exercise have 
been shown to provide significant benefits for reducing 
cardiovascular risk factors. Nevertheless, exercise in 
patients with HCM must be specifically considered 
regarding the risk and benefit. Practicing active lifestyle 
and exercise on HCM individual is an exciting possibility 
that need further study.
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